HEADER HYDROLASE 06-MAR-18 5ZFI TITLE MOUSE KALLIKREIN 7 IN COMPLEX WITH 6-BENZYL-1,4-DIAZEPAN-7-ONE TITLE 2 DERIVATIVE COMPND MOL_ID: 1; COMPND 2 MOLECULE: KALLIKREIN-7; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: SERINE PROTEASE 6,STRATUM CORNEUM CHYMOTRYPTIC ENZYME, COMPND 5 THYMOPSIN; COMPND 6 EC: 3.4.21.117; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: KLK7, PRSS6, SCCE; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEASE, INHIBITOR COMPLEX, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR H.SUGAWARA REVDAT 3 22-NOV-23 5ZFI 1 REMARK REVDAT 2 04-JUL-18 5ZFI 1 JRNL REVDAT 1 27-JUN-18 5ZFI 0 JRNL AUTH H.MURAFUJI,H.SUGAWARA,M.GOTO,Y.OYAMA,H.SAKAI,S.IMAJO, JRNL AUTH 2 T.TOMOO,T.MUTO JRNL TITL STRUCTURE-BASED DRUG DESIGN TO OVERCOME SPECIES DIFFERENCES JRNL TITL 2 IN KALLIKREIN 7 INHIBITION OF 1,3,6-TRISUBSTITUTED JRNL TITL 3 1,4-DIAZEPAN-7-ONES. JRNL REF BIOORG. MED. CHEM. V. 26 3639 2018 JRNL REFN ESSN 1464-3391 JRNL PMID 29884582 JRNL DOI 10.1016/J.BMC.2018.05.044 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH H.MURAFUJI,H.SAKAI,M.GOTO,S.IMAJO,H.SUGAWARA,T.MUTO REMARK 1 TITL DISCOVERY AND STRUCTURE-ACTIVITY RELATIONSHIP STUDY OF REMARK 1 TITL 2 1,3,6-TRISUBSTITUTED 1,4-DIAZEPANE-7-ONES AS NOVEL HUMAN REMARK 1 TITL 3 KALLIKREIN 7 INHIBITORS. REMARK 1 REF BIOORG. MED. CHEM. LETT. V. 27 5272 2017 REMARK 1 REFN ESSN 1464-3405 REMARK 1 PMID 29102227 REMARK 1 DOI 10.1016/J.BMCL.2017.10.030 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0189 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.15 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 90.2 REMARK 3 NUMBER OF REFLECTIONS : 20333 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.188 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 1109 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 909 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 56.68 REMARK 3 BIN R VALUE (WORKING SET) : 0.2810 REMARK 3 BIN FREE R VALUE SET COUNT : 58 REMARK 3 BIN FREE R VALUE : 0.3530 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1716 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 45 REMARK 3 SOLVENT ATOMS : 96 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.86 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.87000 REMARK 3 B22 (A**2) : -8.87000 REMARK 3 B33 (A**2) : 17.74000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.028 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.028 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.080 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.446 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.960 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.942 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1815 ; 0.019 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 1657 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2464 ; 1.276 ; 1.985 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3883 ; 0.642 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 225 ; 7.017 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 66 ;39.303 ;25.152 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 314 ;19.106 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 5 ;21.889 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 268 ; 0.099 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1970 ; 0.018 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 329 ; 0.005 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 898 ; 1.970 ; 2.083 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 896 ; 1.971 ; 2.077 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1120 ; 2.603 ; 3.110 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1121 ; 2.602 ; 3.115 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 917 ; 2.913 ; 2.631 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 917 ; 2.913 ; 2.631 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 1344 ; 4.264 ; 3.796 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 2014 ; 5.927 ;26.407 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 2008 ; 5.922 ;26.303 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 16 A 246 REMARK 3 ORIGIN FOR THE GROUP (A): -18.6103 25.5418 43.3973 REMARK 3 T TENSOR REMARK 3 T11: 0.1439 T22: 0.1285 REMARK 3 T33: 0.0053 T12: -0.0143 REMARK 3 T13: 0.0095 T23: -0.0184 REMARK 3 L TENSOR REMARK 3 L11: 0.5277 L22: 1.1790 REMARK 3 L33: 0.6554 L12: -0.1788 REMARK 3 L13: -0.0714 L23: 0.1439 REMARK 3 S TENSOR REMARK 3 S11: 0.0096 S12: -0.0450 S13: 0.0043 REMARK 3 S21: 0.0472 S22: -0.0413 S23: 0.0480 REMARK 3 S31: 0.0172 S32: -0.0282 S33: 0.0317 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5ZFI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 13-MAR-18. REMARK 100 THE DEPOSITION ID IS D_1300006988. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-JAN-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22651 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.1 REMARK 200 DATA REDUNDANCY : 9.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.83 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.28400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 5ZFH REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.73 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG400, PEG 8000, MAGNESIUM CHLORIDE, REMARK 280 TRIS/HCL, PH 8, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 49.01100 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 35.42500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 35.42500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 73.51650 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 35.42500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 35.42500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 24.50550 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 35.42500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 35.42500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 73.51650 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 35.42500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 35.42500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 24.50550 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 49.01100 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 300 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10610 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 4.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 119 140.73 -170.29 REMARK 500 LYS A 173 -123.66 54.73 REMARK 500 SER A 195 130.96 -39.66 REMARK 500 SER A 214 -55.26 -123.39 REMARK 500 LYS A 243 136.60 -31.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9C9 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue TRS A 302 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5ZFH RELATED DB: PDB REMARK 900 5ZFH CONTAINS SAME APO PROTEIN. DBREF 5ZFI A 16 246 UNP Q91VE3 KLK7_MOUSE 26 249 SEQRES 1 A 224 ILE ILE ASP GLY TYR LYS CYS LYS GLU GLY SER HIS PRO SEQRES 2 A 224 TRP GLN VAL ALA LEU LEU LYS GLY ASN GLN LEU HIS CYS SEQRES 3 A 224 GLY GLY VAL LEU VAL ASP LYS TYR TRP VAL LEU THR ALA SEQRES 4 A 224 ALA HIS CYS LYS MET GLY GLN TYR GLN VAL GLN LEU GLY SEQRES 5 A 224 SER ASP LYS ILE GLY ASP GLN SER ALA GLN LYS ILE LYS SEQRES 6 A 224 ALA THR LYS SER PHE ARG HIS PRO GLY TYR SER THR LYS SEQRES 7 A 224 THR HIS VAL ASN ASP ILE MET LEU VAL ARG LEU ASP GLU SEQRES 8 A 224 PRO VAL LYS MET SER SER LYS VAL GLU ALA VAL GLN LEU SEQRES 9 A 224 PRO GLU HIS CYS GLU PRO PRO GLY THR SER CYS THR VAL SEQRES 10 A 224 SER GLY TRP GLY THR THR THR SER PRO ASP VAL THR PHE SEQRES 11 A 224 PRO SER ASP LEU MET CYS SER ASP VAL LYS LEU ILE SER SEQRES 12 A 224 SER ARG GLU CYS LYS LYS VAL TYR LYS ASP LEU LEU GLY SEQRES 13 A 224 LYS THR MET LEU CYS ALA GLY ILE PRO ASP SER LYS THR SEQRES 14 A 224 ASN THR CYS ASN GLY ASP SER GLY GLY PRO LEU VAL CYS SEQRES 15 A 224 ASN ASP THR LEU GLN GLY LEU VAL SER TRP GLY THR TYR SEQRES 16 A 224 PRO CYS GLY GLN PRO ASN ASP PRO GLY VAL TYR THR GLN SEQRES 17 A 224 VAL CYS LYS TYR LYS ARG TRP VAL MET GLU THR MET LYS SEQRES 18 A 224 THR HIS ARG HET 9C9 A 301 37 HET TRS A 302 8 HETNAM 9C9 2-[(3Z,6R)-6-[(2,6-DICHLOROPHENYL)METHYL]-3- HETNAM 2 9C9 (DIMETHYLHYDRAZINYLIDENE)-7-OXO-1,4-DIAZEPAN-1-YL]-N- HETNAM 3 9C9 [3-(1-METHYL-1H-PYRAZOL-4-YL)PHENYL]ACETAMIDE HETNAM TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL HETSYN TRS TRIS BUFFER FORMUL 2 9C9 C26 H29 CL2 N7 O2 FORMUL 3 TRS C4 H12 N O3 1+ FORMUL 4 HOH *96(H2 O) HELIX 1 AA1 ALA A 55 LYS A 59 5 5 HELIX 2 AA2 SER A 164 LYS A 173 1 10 HELIX 3 AA3 ASP A 174 LEU A 176 5 3 HELIX 4 AA4 TYR A 234 LYS A 243 1 10 SHEET 1 AA1 8 TYR A 20 LYS A 21 0 SHEET 2 AA1 8 MET A 156 ILE A 163 -1 O CYS A 157 N TYR A 20 SHEET 3 AA1 8 MET A 180 GLY A 184 -1 O CYS A 182 N ILE A 163 SHEET 4 AA1 8 GLY A 226 GLN A 230 -1 O TYR A 228 N LEU A 181 SHEET 5 AA1 8 THR A 208 TRP A 215 -1 N TRP A 215 O VAL A 227 SHEET 6 AA1 8 PRO A 198 CYS A 201 -1 N LEU A 199 O GLN A 210 SHEET 7 AA1 8 SER A 135 GLY A 140 -1 N THR A 137 O VAL A 200 SHEET 8 AA1 8 MET A 156 ILE A 163 -1 O MET A 156 N GLY A 140 SHEET 1 AA2 7 GLN A 30 LYS A 35 0 SHEET 2 AA2 7 GLN A 39 ASP A 48 -1 O CYS A 42 N LEU A 33 SHEET 3 AA2 7 TRP A 51 THR A 54 -1 O LEU A 53 N VAL A 45 SHEET 4 AA2 7 MET A 104 LEU A 108 -1 O VAL A 106 N VAL A 52 SHEET 5 AA2 7 GLN A 81 ARG A 90 -1 N PHE A 89 O LEU A 105 SHEET 6 AA2 7 TYR A 64 LEU A 68 -1 N TYR A 64 O ALA A 85 SHEET 7 AA2 7 GLN A 30 LYS A 35 -1 N LEU A 34 O GLN A 65 SSBOND 1 CYS A 22 CYS A 157 1555 1555 2.07 SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.04 SSBOND 3 CYS A 129 CYS A 232 1555 1555 2.05 SSBOND 4 CYS A 136 CYS A 201 1555 1555 2.05 SSBOND 5 CYS A 168 CYS A 182 1555 1555 2.06 SSBOND 6 CYS A 191 CYS A 220 1555 1555 2.06 CISPEP 1 SER A 146 PRO A 147 0 15.86 CISPEP 2 TYR A 218 PRO A 219 0 -5.15 SITE 1 AC1 16 LEU A 40 HIS A 41 HIS A 57 HIS A 99 SITE 2 AC1 16 PHE A 151 THR A 190 CYS A 191 ASN A 192 SITE 3 AC1 16 GLY A 193 SER A 195 VAL A 213 SER A 214 SITE 4 AC1 16 GLY A 216 THR A 217 CYS A 220 HOH A 421 SITE 1 AC2 9 LYS A 21 CYS A 22 GLU A 24 ASP A 71 SITE 2 AC2 9 LYS A 72 PRO A 92 ASP A 154 LEU A 155 SITE 3 AC2 9 HOH A 401 CRYST1 70.850 70.850 98.022 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014114 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014114 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010202 0.00000